HOME | CONTACT | BLOG | SITE MAP   

Press Releases

Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Presents at Prestigious Stem Cell Conference at Case Western Reserve University

July 18, 2013 --

Vet-Stem, Inc., a biotechnology company that develops and markets revolutionary products in the field of Veterinary Regenerative Medicine, announced that Chief Executive Officer, Robert J. Harman, DVM, presented this week at the Case Western Reserve University meeting “The Business of Regenerative Medicine: From Stem Cells to the Market Place” in Cleveland, Ohio.  Dr. Harman has been a regular presenter at this prestigious meeting, providing insights into the commercialization of stem cell technology in the veterinary field. 

 

Dr. Harman spoke as part of the New Leadership in Regenerative Medicine Session describing the outcomes and business metrics from more than 10,000 horse, dog and cat patients treated over the last 10 years in both the U.S. and Canada using proprietary Vet-Stem technology.  

 

Dr. Harman, the only presenter from the veterinary field, presented along with more than 20 other leading companies in the regenerative medicine field.  The CEOs of OSIRIS, BioTime, Mesoblast and the Directors of the Harvard Stem Cell Institute, and Genetics Policy Institute, along with many other global leaders also spoke. 

 

Arnold I. Caplan, PhD, the meeting organizer and technology pioneer in cell-based therapies in Regenerative Medicine, is a scientific advisor to Vet-Stem, Inc.

 

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession.  The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals.  As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine.  The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells.  In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure.  For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit www.vet-stem.com or call 858-748-2004.





< Back to Press Releases     

 


  • Success Stories
    News
    Videos
    Blog
    Press Releases
    Facebook
    Twitter
     


      COMPANY
    Management
    Investors
    Contact Us
    Careers
    SCIENCE
    FAQs
    Literature Refs
    Safety
    PET & HORSE OWNERS
    Dogs & Cats
    Horses
    Locate a Vet
    FAQs
    VETERINARIANS
    Vet Login /
    Credentialing

    Dogs & Cats
    Horses
    FAQs
    MEDIA ROOM
    Press Releases
    Success Stories
    News
    Videos
    Blog
    LOCATE A VET

    CONTACT US
     

    COPYRIGHT 2011 VETSTEM BIOPHARMA. ALL RIGHTS RESERVED.
    12860 Danielson Court, Suite B, Poway, CA 92064 Phone: 858-748-2004 or 888-387-8361